Novel Chitosan Derivative Nanoparticles Enhance the Immunogenicity of a DNA Vaccine Encoding Hepatitis B Virus Core Antigen in Mice

Lei Jiang,Feng Qian,Xiaowen he,Fang Wang,Ding Ren,Ying He,Ka Li,Shuhan Sun,Chunhua Yin
DOI: https://doi.org/10.1002/jgm.1017
2007-01-01
Abstract:Background Chitosan has been shown to possess useful properties such as non-toxicity, high biocompatibility and non-antigenicity that offer advantages for vaccine delivery systems. In this study, we prepared novel chitosan derivative nanoparticles as DNA vaccine carriers and the potential and mechanism of the DNA-nanoparticle complexes in inducing augmented immune responses were explored.Methods The pVAX(HBc)DNA-nanoparticle complexes as vaccine delivery systems were studied in several aspects: the protection against DNase I degradation was measured by an in vitro inhibition assay; the sustained expression of the plasmid in vivo was determined by RT-PCR; the elevated uptake efficiency by phagocytes was observed with confocal microscopy; the biocompatibility was evaluated by cytotoxicity and histology assay; the complexes were administrated to C57BL/6 mice and the humoral and cellular immune responses were evaluated by ELISA, IFN-gamma production and cytolytic T lymphocyte (CTL)-specific lysis assay.Results The remaining relative activity of DNase I after inhibition varied from 32.3% to 77.6%. The Complexes were observed with higher uptake efficiency by phagocytes than naked DNA. Three types of nanoparticles did not induce significant cyLotoxicity at concentrations <= 400 mu g/ml. No specific histological alteration related to the injection of the complexes was observed. The formulations of DNA-nanoparticle complexes significantly enhanced the immunogenicity in several parameters: elevated antibody production, higher level of IFN-gamma secretion, and augmented specific cell lysis.Conclusions This study demonstrated the potential of the novel chitosan derivative nanoparticles for safe and effective DNA vaccine delivery. (c) Copyright 2007 John Wiley & Sons, Ltd.
What problem does this paper attempt to address?